Highlights From the American Heart Association's EPI|Lifestyle Scientific Sessions 2023
Amelia S. Wallace,Oluwabunmi Ogungbe,Elisabeth L. P. Sattler,Emily Aidoo,Tara S. Allen,Lauren Bernard,Yingan Chen,Shutong Du,Taynara Formagini,Bamba Gaye,Ben King,Sohyeon Kwon,Fredrick Larbi Kwapong,Tiange Liu,Nour Makarem,Heidy Mendez-Rodriguez,Faith E. Metlock,Shirine Moukaled,Amy R. Nichols,Bige Ozkan,Rupal Trivedi,Ruth-Alma Turkson-Ocran,Frances M. Wang,Caroline Wang,Yunwen Xu,Christina Y. Yin,Mingyu Zhang,Alvaro Alonso,Marie-France Hivert
DOI: https://doi.org/10.1161/JAHA.123.029894
IF: 6.106
2023-01-01
Journal of the American Heart Association
Abstract:HomeJournal of the American Heart AssociationVol. 12, No. 20Highlights From the American Heart Association's EPI|Lifestyle Scientific Sessions 2023 Open AccessMeeting ReportPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toOpen AccessMeeting ReportPDF/EPUBHighlights From the American Heart Association's EPI|Lifestyle Scientific Sessions 2023 Amelia S. Wallace, Oluwabunmi Ogungbe, Elisabeth L. P. Sattler, Emily Aidoo, Tara S. Allen, Lauren Bernard, Yingan Chen, Shutong Du, Taynara Formagini, Bamba Gaye, Ben King, Sohyeon Kwon, Fredrick Larbi Kwapong, Tiange Liu, Nour Makarem, Heidy Mendez‐Rodriguez, Faith E. Metlock, Shirine Moukaled, Amy R. Nichols, Bige Ozkan, Rupal Trivedi, Ruth‐Alma Turkson‐Ocran, Frances M. Wang, Caroline Wang, Yunwen Xu, Christina Y. Yin, Mingyu Zhang, Alvaro Alonso and Marie‐France Hivert Amelia S. WallaceAmelia S. Wallace * Correspondence to: Amelia S. Wallace, PhD, MS, Department of Epidemiology, Welch Center for Prevention, Epidemiology and Clinical Research and the Johns Hopkins Bloomberg School of Public Health; 2024 E Monument Street, Suite 2‐600; Baltimore, MD 21287. Email: E-mail Address: [email protected] https://orcid.org/0000-0002-1466-3791 , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Oluwabunmi OgungbeOluwabunmi Ogungbe https://orcid.org/0000-0003-1813-0906 , Johns Hopkins School of Nursing, , Baltimore, , MD, , USA, , Elisabeth L. P. SattlerElisabeth L. P. Sattler https://orcid.org/0000-0002-6379-7892 , Department of Clinical and Administrative Pharmacy, College of Pharmacy, , University of Georgia, , Athens, , GA, , USA, , Department of Nutritional Sciences, College of Family and Consumer Sciences, , University of Georgia, , Athens, , GA, , USA, , Emily AidooEmily Aidoo https://orcid.org/0000-0002-8959-505X , Department of General Medicine, Beth Israel Deaconess Medical Center, , Harvard Medical School, , Boston, , MA, , USA, , Tara S. AllenTara S. Allen , Division of Preventive Medicine, Department of Family Medicine, , University of California, San Diego, , San Diego, , CA, , USA, , Lauren BernardLauren Bernard https://orcid.org/0000-0001-5747-3747 , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Yingan ChenYingan Chen , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Shutong DuShutong Du , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Taynara FormaginiTaynara Formagini https://orcid.org/0000-0001-9318-5734 , Department of Family Medicine and Public Health, , University of California San Diego, , San Diego, , CA, , USA, , Institute for Behavioral & Community Health, , San Diego State University, , San Diego, , CA, , USA, , Bamba GayeBamba Gaye https://orcid.org/0000-0002-5516-4665 , Department of Epidemiology, , INSERM, U970, Paris Cardiovascular Research Center, , Paris, , France, , Paris Cardiovascular Research Centre, , Université de Paris, INSERM, , Paris, , France, , Ben KingBen King , Tilman J Fertitta Family College of Medicine, Department of Health Systems and Population Health Sciences, , University of Houston, , Houston, , TX, , USA, , Humana Integrated Health Systems Sciences Institute, , University of Houston, , Houston, , TX, , USA, , Sohyeon KwonSohyeon Kwon https://orcid.org/0000-0003-2307-4160 , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Fredrick Larbi KwapongFredrick Larbi Kwapong https://orcid.org/0000-0002-5585-632X , Department of General Medicine, Beth Israel Deaconess Medical Center, , Harvard Medical School, , Boston, , MA, , USA, , Tiange LiuTiange Liu https://orcid.org/0000-0003-2486-8691 , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Nour MakaremNour Makarem https://orcid.org/0000-0001-5230-8689 , Department of Epidemiology, Mailman School of Public Health, , Columbia University Irving Medical Center, , New York, , NY, , USA, , Heidy Mendez‐RodriguezHeidy Mendez‐Rodriguez https://orcid.org/0000-0002-7803-6770 , San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, , San Diego, , CA, , USA, , Faith E. MetlockFaith E. Metlock , Johns Hopkins School of Nursing, , Baltimore, , MD, , USA, , Shirine MoukaledShirine Moukaled https://orcid.org/0000-0001-5421-8038 , Department of Epidemiology, , Tulane University School of Public Health and Tropical Medicine, , New Orleans, , LA, , USA, , Amy R. NicholsAmy R. Nichols https://orcid.org/0000-0002-3085-7377 , Department of Nutrition, , Harvard T.H. Chan School of Public Health, , Boston, , MA, , USA, , Department of Population Medicine, , Harvard Medical School, , Boston, , MA, , USA, , Harvard Pilgrim Health Care Institute, , Boston, , MA, , USA, , Bige OzkanBige Ozkan https://orcid.org/0000-0003-2745-1189 , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, , Johns Hopkins University School of Medicine, , Baltimore, , MD, , USA, , Rupal TrivediRupal Trivedi , Department of Clinical and Administrative Pharmacy, College of Pharmacy, , University of Georgia, , Athens, , GA, , USA, , Ruth‐Alma Turkson‐OcranRuth‐Alma Turkson‐Ocran https://orcid.org/0000-0001-9932-052X , Department of General Medicine, Beth Israel Deaconess Medical Center, , Harvard Medical School, , Boston, , MA, , USA, , Frances M. WangFrances M. Wang https://orcid.org/0000-0003-4950-582X , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Caroline WangCaroline Wang , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Welch Center for Prevention, Epidemiology, and Clinical Research, , Johns Hopkins University, , Baltimore, , MD, , USA, , Yunwen XuYunwen Xu https://orcid.org/0000-0002-5946-2272 , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Christina Y. YinChristina Y. Yin , Department of Epidemiology, , Johns Hopkins Bloomberg School of Public Health, , Baltimore, , MD, , USA, , Mingyu ZhangMingyu Zhang https://orcid.org/0000-0003-3628-0983 , Department of Population Medicine, , Harvard Medical School, , Boston, , MA, , USA, , Harvard Pilgrim Health Care Institute, , Boston, , MA, , USA, , Alvaro AlonsoAlvaro Alonso https://orcid.org/0000-0002-2225-8323 , Department of Epidemiology, Rollins School of Public Health, , Emory University, , Atlanta, , GA, , USA, and Marie‐France HivertMarie‐France Hivert https://orcid.org/0000-0001-7752-2585 , Department of Population Medicine, , Harvard Medical School, , Boston, , MA, , USA, , Harvard Pilgrim Health Care Institute, , Boston, , MA, , USA, , Diabetes Unit, , Massachusetts General Hospital, , Boston, , MA, , USA, Originally published7 Oct 2023https://doi.org/10.1161/JAHA.123.029894Journal of the American Heart Association. 2023;12:e029894Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: October 7, 2023: Ahead of Print The 2023 American Heart Association (AHA) EPI|Lifestyle Scientific Sessions, cosponsored by the AHA Council on Epidemiology and Prevention (EPI) and the AHA Council on Lifestyle and Cardiometabolic Health (Lifestyle) to support research into population‐based approaches to reduce cardiovascular disease (CVD) and improve cardiovascular health (CVH), took place from March 1 to 3 in Boston, Massachusetts. The theme was “From Science to Action: Implementing Knowledge for Healthy Hearts” and featured implementation science approaches for applying CVD research in real‐world settings. A total of 876 participants, including trainees, public health professionals, and clinicians, attended the meeting, which featured 531 poster presentations, 78 moderated posters, and 69 oral presentations.1 The meeting was chaired by Dr Marie‐France Hivert, Harvard Medical School, representing the Lifestyle Council, and Dr Alvaro Alonso, Emory University, representing the EPI Council. The vice chairs were Dr Monica Serra, University of Texas (UT) Health San Antonio (Lifestyle), and Dr Priya Palta, University of North Carolina at Chapel Hill (EPI).Opening Remarks and Keynote SessionThe opening session began with an overview of this year's AHA initiatives from AHA president Dr Michelle A. Albert, University of California (UC), San Francisco. She emphasized the importance of translating scientific evidence into implementation, particularly among marginalized communities, and announced AHA's 2024 impact goal of advancing CVH for all by identifying and removing barriers to health care access.The first keynote speaker, Dr Crystal Wiley Cené, UC San Diego, highlighted existing evidence‐to‐practice gaps in implementation science research in achieving CVH equity. Evidence‐based interventions are often less effective in historically marginalized populations, and she called for equity‐minded, adaptive designs and more rigorous examination of implementation strategies.2Dr Josiemer Mattei, Harvard University, shared her work on developing an optimized Mediterranean diet specifically for Puerto Ricans and discussed culturally adapted diets for broader implementation in clinical and population‐based disease prevention programs.3 She also emphasized that translating evidence‐based programs takes time and researchers should trust their expertise and confidently implement their work.Dr Sara Bleich, Harvard University (formerly US Department of Agriculture), concluded the session with advice for turning research into policies and action. She stressed the importance of clear and effective communication when presenting evidence to policy stakeholders. A key takeaway: science can find solutions to pressing problems, but policy actions are needed to turn those solutions into reality.Memorial Lectures and Special SessionsDavid Kritchevsky Memorial LectureDr Shiriki Kumanyika, University of Pennsylvania, presented the David Kritchevsky Memorial Lecture, promoting implementation science as a pathway to equity‐competent obesity solutions. She shared context and considerations for conducting place‐based research including at faith‐based organizations, educational settings, and other community venues.An oral abstract session on nutrition followed Dr Kumanyika's lecture. First, Dr Valerie Sullivan, Johns Hopkins University, found that greater ultra‐processed food intake is associated with chronic kidney disease progression and increased risk of all‐cause death in adults with chronic kidney disease. Dr Katherine Mills, Tulane University, showed that a randomized trial of a dietitian‐led dietary sodium reduction intervention significantly reduced dietary sodium and blood pressure (BP) in patients with chronic kidney disease and albuminuria. Kenny Mendoza, PhD student from Harvard University, found that women with higher long‐term ultra‐processed food intake, particularly sugary drinks and animal‐based products, had a higher CVD risk, even with an otherwise high‐quality diet. Finally, Dr Howard Sesso, Brigham and Women's Hospital, reported findings from a pilot study showing that cocoa extract and multivitamin supplementation may alter the gut microbiome.Frederick H. Epstein Memorial Lecture and Cardiometabolic Risk PredictionThe Frederick H. Epstein Memorial Lecture, “Reimagining Prevention, Aspiring to Global Health Equity in a Post‐COVID‐19 World,” was given by Dr Sandro Galea, Boston University. His talk, which discussed the implications of COVID‐19 on future health promotion and disease prevention techniques, emphasized that reimagining public health should center around equity, use better science to guide decision making, and include self‐awareness by researchers for more consequential scholarship.An oral abstract session on cardiometabolic risk prediction followed Dr Galea's lecture. Dr Rosangela Hoshi, Brigham and Women's Hospital, showed that an immunoglobulin G N‐glycan–based score was positively associated with cardiovascular events, with reproducible results in 2 randomized trials. Dr Yoriko Heianza, Tulane University, found that comprehensive metabolomic risk scores were strongly related to the risk of incident coronary heart disease (CHD) events among women and that diet may mediate associations between CHD risk–related metabolites and atherosclerotic CVD risk. Dr Jose Medina‐Inojosa, Mayo Clinic, applied artificial intelligence algorithms to ECGs to detect coronary calcification. The coronary calcification–ECG algorithm was independently associated with long‐term atherosclerotic CVD events and improved risk models. Finally, Dr So Mi Jemma Cho, Broad Institute, showed that high genetic predisposition to CHD, low high‐density lipoprotein cholesterol, and younger age at primary CHD event most strongly explained CHD recurrence; however, the majority of CHD recurrence risk remained unexplained.William B. Kannel Memorial Lectureship in Preventive CardiologyDr Lori Mosca, Columbia University, presented the William B. Kannel Memorial Lecture. Her talk, “The Power of Patterns, Pioneers and Prevention,” discussed the evolution of CVD epidemiology from the Framingham Heart Study, which began >70 years ago, to the present. She noted that despite overall improvements, biological sex‐based disparities in CVD identification, presentation, and treatment are still present. She concluded with the need for equity and mentorship and emphasized the need to recognize the potential in the current generation of scientists and health care workers.An oral abstract session on preventive cardiology followed Dr Mosca's lecture. Dr Veronica McCloskey, Cano Health, presented results of a nurse practitioner–led program that led to improvements in reaching low‐density lipoprotein and systolic BP targets. Dr Angela Thompson‐Paul, Centers for Disease Control and Prevention, found that lipid screening in US youth was underused, but varied by age, body mass index (BMI), and race and ethnicity. Using data from the National Health and Nutrition Examination Survey, Dr Nour Makarem, Columbia University, found that the new Life's Essential 8 (LE8) score was a strong predictor of all‐cause, CVD, and cancer‐related death in US adults. In the final presentation, Dr Xuan Wang, Tulane University, found that in the UK Biobank Study, a high level of CVH, evaluated using metrics from LE8, was associated with longer life expectancy free of major chronic diseases.AHA Guidelines and StatementsDr Seth Martin, Johns Hopkins University, presented the 2023 AHA Heart Disease and Stroke Statistics.4 This report provides the latest data on heart and circulatory disease conditions and associated outcomes, emphasizing health equity and the impact of structural racism on health. Dr Michael Grandner, University of Arizona, introduced the LE8 checklist for assessing CVH.5 Updated from Life's Simple 7, LE8 introduces a sleep health metric and updates existing metrics such as diet, nicotine exposure, and blood glucose. Dr Nathalie Moise, Columbia University, presented the AHA Scientific Statement on leveraging implementation science for CVH equity.2 The statement offers a road map and checklist with health equity considerations for selecting, adapting, and evaluating evidence‐based practices and implementation strategies to reduce cardiovascular disparities. Dr Gbenga Ogedegbe, New York University, shared the latest developments related to the Health Equity Research Network on Prevention of Hypertension. This network, which received $20 million in funding from the AHA, brings together researchers from >8 institutions to address racial disparities in CVH outcomes by implementing evidence‐based hypertension prevention interventions in community settings. Dr Sadiya Khan, Northwestern University, emphasized the importance of prepregnancy CVH to reduce the risk of adverse pregnancy outcomes and cardiovascular disease for both birthing individuals and their offspring.6 She highlighted the need for a life‐course and intergenerational approach that addresses structural racism and inadequate health care through community‐level interventions and policy changes.Annual American Society of Preventive Cardiology DebateThe annual American Society of Preventive Cardiology debate focused on universal screening of lipoprotein(a) [Lp(a)], a variant of low‐density lipoprotein cholesterol. Dr Allan Sniderman, McGill University, argued for universal Lp(a) screening, and Dr Ann Marie Navar, UT Southwestern, argued that the evidence for universal screening is currently insufficient. The session was moderated by Dr Erin Michos, Johns Hopkins University.Dr Sniderman opened with evidence of the associations between Lp(a) and CVD, which are independent of traditional risk factors. He asserted that Lp(a) testing provides a more comprehensive assessment of patients' overall cholesterol levels than low‐density lipoprotein alone. Therefore, he argued, Lp(a) levels could be valuable for enhancing CVD risk stratification and guiding medicinal management, especially in young people.Dr Navar responded that there are few cases in which Lp(a) testing would change the clinical management of patients, particularly in low‐ and high‐risk populations. Dr Navar called for more studies to provide a better understanding of longitudinal changes in Lp(a), especially after lipid‐lowering therapy.The audience argued for potential benefits of incorporating Lp(a) in practice, including managing familial hypertension, primary CVD risk screening, and medication/therapeutic adherence. Drs Sniderman, Navar, and Michos finally agreed that Lp(a) is a promising biomarker in preventive cardiology, but further research is needed into its potential clinical implications on risk prediction and medical management.Cardiovascular Behavioral Medicine and Implementation ScienceThe session on cardiovascular behavioral medicine was planned in collaboration with the Society of Behavioral Medicine. Moderators Dr Allison Gaffey, Yale University, and Dr Laura Hayman, University of Massachusetts–Boston, began the session by describing cardiovascular behavioral medicine, a health psychology specialty. Dr Alyssa Vela, Northwestern University, and Dr Gaffey discussed the cardiovascular behavioral medicine philosophy and opportunities for stigma reduction and increased access to care in CVD management.Following these talks, oral abstracts highlighted the importance of integrating health behaviors into cardiovascular medicine. In a randomized crossover trial, Dr Keith Diaz, Columbia University, demonstrated that varying frequency and duration of breaks from sedentarism improved blood glucose, systolic BP, mood, and fatigue. Dr Christopher Kline, University of Pittsburgh, showed that better sleep was associated with increased adherence to lifestyle modifications, including session attendance, adherence to calorie goals, and increased physical activity (PA) in a behavioral weight loss intervention trial. Dr Li Yi, Harvard University, presented novel methods for evaluating behavioral, lifestyle, and environmental exposures in future cardiometabolic research using smartphone‐collected data, including location, accelerometer, sleep, and social network use. Finally, in a cluster‐randomized trial, Dr Joreintje Mackenbach, Amsterdam University Medical Centers, showed that supermarket nudging and pricing strategies did not improve individuals' purchasing and dietary behaviors.Oral AbstractsHealth Disparities and Social Determinants of HealthDr Utibe Essien, UC Los Angeles, began the session by showing that higher medication copays among patients with diabetes or heart failure were associated with lower medication adherence, even after adjusting for income and socioeconomic status. Adam Whalen, Albert Einstein College of Medicine, using the HCHS/SOL (Hispanic Community Health Study/Study of Latinos), showed that downward mobility (moving from higher socioeconomic status in childhood to lower socioeconomic status in adulthood) was associated with increased all‐cause death. Dr Timiya Nolan, The Ohio State University, described the development of a community initiative to uplift and empower Black women. Nicholas Roberts, MD student at Weill Cornell Medicine, found increased prevalence of hypertension and CVD among Haitians living in neighborhoods with high social vulnerability. Dr Ifedioranma Anikpo, University of Miami, showed that compared with US‐born Black adults, Black immigrants had a lower risk of obesity and hypertension. However, longer time spent in the United States attenuated this benefit, suggesting that US acculturation may play a role in the development of cardiometabolic disease. Dr Wayne Lawrence, National Cancer Institute, using the MESA (Multi‐ethnic Study of Atherosclerosis) found that experiences of lifetime and everyday discrimination were associated with increased CVD‐related death among Black individuals, particularly among Black men.Cardiometabolic Health and DiseaseStarting off the session, Dr Nwabunie Nwana, Houston Methodist, showed that exposure to higher levels of particulate matter ≤2.5 μm was associated with a greater prevalence of hypertension, diabetes, smoking, and obesity but not with dyslipidemia. Shirine Moukaled, PhD student from Tulane University, demonstrated that Black participants and those with lower socioeconomic status in the Bogalusa Heart Study had a greater multimorbidity burden—most commonly dyslipidemia, hypertension, and diabetes. Zailing Xing, PhD student from the University of South Florida, evaluated insulin resistance patterns in the ARIC (Atherosclerosis Risk in Communities) study, and showed that women with “high‐decreasing” insulin resistance trajectory had higher risk of death. Stably high insulin resistance was associated with increased risk of heart failure among both men and women. Dr Hokyou Lee, Yonsei University, derived a modified Life's Simple 7 score and showed that individuals with lower cumulative CVH scores had higher risk of incident CVD. Rounding out the session, Dr Zakaria Almuwaqat, Emory University, showed that higher BMI was associated with greater risk of myocardial infarction and cardiovascular death but not with risk of stroke.Maternal and Child Cardiometabolic Disease PreventionNatasha Morales‐Ghinaglia, PhD student from Pennsylvania State University, began the session showing that circadian misalignment of the sleep–wake cycle in adolescents was linked with impaired cardiac autonomic modulation and may contribute to CVD risk. Tiange Liu, PhD student from Johns Hopkins University, showed that higher gut microbiome diversity in infants was associated with lower BP later in childhood, though only among infants breastfed for at least 1 year. Dr Siwen Wang, Harvard University, found that maintaining a normal BMI, not smoking, regular exercise, healthy diet, avoiding harmful alcohol intake, and multivitamin supplementation were associated with lower risk of adverse pregnancy outcomes. Emily Ash, Medical University of South Carolina, reported that women with prepregnancy hypertension, hypertensive disorders of pregnancy, and diabetes in pregnancy faced an increased risk of CHD and maternal all‐cause death within 5 years of delivery; non‐Hispanic Black women had higher risks than non‐Hispanic White women. Katherine Campbell, PhD student at Emory University, found that women giving birth in metro Atlanta who lived in regions with greater daytime racial segregation and income disparities had higher odds of hypertensive disorders of pregnancy than those living in regions with less segregation and lower income disparities. Finally, Dr Sofie Taageby Nielsen, Copenhagen University, demonstrated that preeclampsia was associated with increased risk of maternal future CVD and higher lipid concentrations in umbilical cord blood of their offspring.Mixing up the 'OmicsThe 'omics session featured presentations on genomics, microbiome, metabolomics, and proteomics. Dr Abbas Dehghan, Imperial College London, found genetic loci associated with carotid artery intima‐media thickness. In a Mendelian randomization analysis of these loci, they found evidence of a bidirectional relationship between carotid artery intima‐media thickness and hypertension. Dr Hao Ma, Tulane University, showed that higher DNA methylation of the gene TXNIP was associated with lower fasting glucose in midlife among participants from the Bogalusa Heart Study, particularly in those with a larger increase in BMI from childhood to adolescence. Dr Nicole Armstrong, University of Alabama at Birmingham, found that African Americans with a lower systolic BP polygenic risk score had a greater decrease in systolic BP with chlorthalidone treatment and lower odds of developing treatment‐resistant hypertension. Dr Brandilyn Peters, Albert Einstein College of Medicine, showed an association between kidney function and gut microbiome diversity and composition in the HCHS/SOL. Dr Zhila Semnani‐Azad, Harvard University, found 23 metabolite networks and individual metabolites that were associated with child adiposity at age 5. Finally, Dr Bige Ozkan, Johns Hopkins University, found inflammatory and metabolic pathways that were associated with BMI, independent of traditional cardiovascular risk factors in the ARIC study.PA, Sedentary Behaviors, and SleepOpening the session on PA and sleep, Dr Aboubakari Nambiema, Université Paris Cité, showed that higher sleep scores and improving sleep scores over time were related to a lower risk of CHD. Dr Steve Nguyen, UC San Diego, found that higher sitting time and mean sitting bout duration were associated with higher CVD and all‐cause mortality risk among women. Dr Neela Thangada, Northwestern University, showed that in the CARDIA (Coronary Artery Risk Development in Young Adults) study, higher early adulthood cardiorespiratory fitness and its retention in midlife was associated with a lower risk of subclinical or clinical heart failure. Dr Mauro Mediano, Oswaldo Cruz Foundation, found that in HCHS/SOL, PA fragmentation, or having PA broken up into short bouts, was associated with death, independent of daily PA volume. Dr Minkyoung Song, Oregon Health and Science University, found that one‐third of US children did not meet the recommended sleep duration on the basis of LE8 criteria. Dr Erin Dooley, University of Alabama at Birmingham, showed that more daily steps were associated with lower risk of CVD events among older adults in the ARIC study.Jeremiah and Rose Stamler Research Award Finalist PresentationsThis year's Stamler award was presented to Dr Xiang Li from Tulane University. Dr Li observed that LE8, which adds a sleep health component, outperforms Life's Simple 7 at predicting CVH outcomes, including CHD, stroke, and CVD. Dr Hao Ma, Tulane University, found that at age 50, the average life expectancy was nearly 9 years longer among National Health and Nutrition Examination Survey participants with high CVH compared with participants with low CVH. Dr Bige Ozkan, Johns Hopkins University, found plasma proteins that were associated with both heart failure risk and obesity in middle‐aged adults from the ARIC study, which may indicate a mediating effect of these proteins in obesity‐related heart failure. Farah Allouch, PhD student from Tulane University, found that a 2‐question antihypertension medication adherence score was associated with BP control and CVD outcomes in multinational low‐income populations. Finally, Dr Nilay Shah, Northwestern University, reported that in middle‐aged adults from MESA, higher CVH was significantly associated with time lived free of coronary calcification, but no association was seen in older adults.Aging and Brain HealthKristine Moseholm, PhD student at the University of Copenhagen, showed that higher plasma levels of short‐chain ceramide and sphingomyelin were associated with faster cognitive decline, while higher levels of very‐long‐chain sphingomyelin were associated with lower risk of dementia and slower cognitive decline. Dr Nzechukwu Isiozor, University of Eastern Finland, found that a higher LE8 score was associated with a lower risk of stroke. Dr Jun Li, Brigham and Women's Hospital, found that the cortical transcriptomic profile for a Mediterranean‐style diet was associated with slower cognitive decline and lower odds of dementia. Dr Laura Skow, Johns Hopkins University, found that older adults who had diabetes and hypertension in midlife had faster physical function declines in late life. Using National Health and Nutrition Examination Survey data, Dr Aline Thomas, Columbia Unive